ALYSON SIRAGUSA: Open Payments
NPI 1841987328 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 15 payments from 9 companies in 2025. Trend: 2023 $78 · 2024 $711 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $149 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| ABBVIE INC. | 1 | $34 |
| SANOFI PASTEUR INC. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Orexo US, Inc. | 1 | $15 |
Products named: VOQUEZNA, REXULTI, ZEPBOUND, QULIPTA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, GEMTESA, Cologuard Collection Kit, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
